As an epidemiologist and physician, I’ve long been concerned about how health interventions for marginalized communities are evaluated. A new study explores that concern and offers some solutions for ...

CAR-T therapy's cost per QALY is approximately $100,000, with consistent results across PSM, STM, and DES models. DES uniquely incorporates wait time, significantly affecting CAR-T's ...

Real-World Outcomes in Anaplastic Lymphoma Kinase–Positive Advanced Non–Small Cell Lung Cancer in Argentina: A Multicenter Retrospective Study (GAOT-ALK001) To estimate the size of the population ...

A study by ICMR-NIRT has found that shorter, six-month all-oral regimens for drug-resistant TB, like BPaL, are more effective ...

Large-Scale Pharmacogenomics Analysis of Patients With Cancer Within the 100,000 Genomes Project Combining Whole-Genome Sequencing and Medical Records to Inform Clinical Practice SOC was dominated by ...

Lifetime treatment with statins is a cost-effective therapy across a wide range of elderly patients with and without cardiovascular disease, according to an analysis published this week in Heart.

Based on this analysis, all 3 gepants are not cost-effective compared with usual care for the treatment of acute migraine. Objective: Migraine is a debilitating chronic disorder requiring multifaceted ...

A new analysis from the Institute for Clinical and Economic Review has found that blockbuster GLP-1 drugs from Novo Nordisk and Eli Lilly offer substantial health benefits and are a cost-effective ...

Please provide your email address to receive an email when new articles are posted on . The impact of cost must be considered when selecting a glaucoma treatment. Earlier glaucoma diagnosis and ...

ICMR study finds shorter all-oral regimens for drug-resistant TB are cost-effective and improve health outcomes in India.